Literature DB >> 16567315

[Parathyroid carcinoma].

Gilles Poissonnet1, Laurent Castillo, Alexandre Bozec, Isabelle Peyrottes, Francette Ettore, José Santini, François Demard, Olivier Dassonville.   

Abstract

Parathyroid carcinoma is a rare disease accounting for 1 to 5% of parathyroid neoplasms. This malignant tumour must be suspected when a severe primary hyperparathyroidism occurs with high hypercalcemia and elevated parathormon levels. At this time, a cervical mass is often palpable. Both head and neck ultrasonography and 99mTc-sestamibi scintigraphy are the best preoperative imaging tests to suspect and localize the tumour. Surgical approach with simultaneous tumorectomy and hemithyroidectomy, completed by selective neck dissection (level VI) is the treatment of choice. An elective lateral neck dissection should be performed if necessary. Tumour control should be monitored by regular measurement of calcium and parathormon levels. Local recurrence or metastasis risk is 30 to 70% and the 5 year overall survival about 50 to 80%. In case of recurrence, aggressive surgical management should be applied and adjuvant radiation therapy may be discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16567315

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

1.  [Giant parathyroid carcinoma: diagnostic difficulties and therapeutic strategies].

Authors:  Ilias Benchafai; Leila Afani; Noureddine Errami; Bouchaib Hemmaoui; Hassan Errihani; Fouad Benariba
Journal:  Pan Afr Med J       Date:  2017-04-19

2.  Giant parathyroid carcinoma: Diagnostic, difficulties and therapeutic strategies: A case report.

Authors:  Laila Bouzayan; Mohamed Yassine Mabrouk; Hassane Ait Ali; Abdelali Guelil; Achraf Miry; Jabi Rachid; Amal Benani; Mohammed Bouziane
Journal:  Ann Med Surg (Lond)       Date:  2021-10-09

3.  Intrathyroidal parathyroid carcinoma: a case report with clinical and histological findings.

Authors:  Labiba Temmim; Fred Sinowatz; Wiam I Hussein; Osama Al-Sanea; Hady El-Khodary
Journal:  Diagn Pathol       Date:  2008-11-25       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.